Related Experiment Videos
Screening performance of consensus definition of fetal growth restriction inappropriately evaluated - Authors' reply
Ulla Sovio1, Gordon C S Smith1
1Department of Obstetrics and Gynaecology, NIHR Biomedical Research Centre, University of Cambridge, Cambridge CB2 0SW, UK.
The Lancet. Child & Adolescent Health
|August 19, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mendelian Randomization With Longitudinal Exposure Data: Simulation Study and Real Data Application.
Statistics in medicine·2026
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold-Standard Clinical Models in Multiethnic Populations.
Journal of the American Heart Association·2025
How Should We Communicate Information Regarding Birth Choices to Women?: An Online Randomised Survey.
BJOG : an international journal of obstetrics and gynaecology·2025
Opportunities for advancing paediatric medical device access: regulatory frameworks in the EU and USA.
The Lancet. Child & adolescent health·2026
Injury burden among adolescents and young adults aged 10-24 years in the Arab region, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023.
The Lancet. Child & adolescent health·2026
Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-label, non-inferiority, randomised controlled trial.
The Lancet. Child & adolescent health·2026
Comparative effectiveness of clarithromycin and azithromycin for pertussis in hospitalised infants in Italy: a multicentre target trial emulation study.
The Lancet. Child & adolescent health·2026
Paediatric Drug Optimization for Sickle Cell Disease: priorities for research and development in children.
The Lancet. Child & adolescent health·2026
Adolescent health across Asia Pacific, 2000-23: a systematic analysis for the Global Burden of Disease Study 2023.
The Lancet. Child & adolescent health·2026
Donanemab for early symptomatic AD in the UK-indicated population: safety and efficacy in those who are non-carriers or heterozygous for APOE ε4.
Neurodegenerative disease management·2026
Nail Involvement in Refractory Pediatric Alopecia Areata: A Duration-Dependent Finding.
Skin appendage disorders·2026